Search for: "Teva Pharmaceuticals" Results 21 - 40 of 1,419
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
30 Oct 2014, 11:34 am by Lawrence B. Ebert
Note Reuters post Teva optimistic U.S. top court to rule in favor of MS drug patent with textTeva Pharmaceutical Industries is optimistic the U.S. [read post]
2 Oct 2023, 6:00 am by Overhauser Law Offices, LLC
Massachusetts – Judge Allison Burroughs sided with Eli Lilly in a dispute with Teva Pharmaceuticals, overturning a $176.5 million jury verdict that had previously been awarded to Teva in a patent infringement suit regarding the two companies’ development of drugs with antibodies capable of treating headache disorders associated with calcitonin gene-related peptide (“CGRP”). [read post]
31 Oct 2011, 5:42 pm
San Diego - Last week, Pfizer announced its victory in a patent infringement battle with Teva Pharmaceuticals USA, Inc. in the United States District Court for the Eastern District of Virginia. [read post]
23 Apr 2010, 3:49 pm by Lawrence B. Ebert
On April 23, 2010, a New Jersey jury found claims of a Pfizer patent covering the Protonix acid reflux drug (pantoprazole ) valid and infringed by Teva Pharmaceutical Industries.See previous IPBiz post: Wyeth undercuts Teva on Protonix The original patent was to Swiss drugmaker Nycomed and was licensed to Wyeth, which is now owned by Pfizer. [read post]
10 Feb 2014, 7:01 pm by H. Scott Leviant
Teva Pharmaceuticals USA, Inc. was described as the end of the world by business interests when the Ninth Circuit held that attorneys could avoid CAFA removal by filing separate cases with fewer than 100 plaintiffs in each case to avoid the mass action provision in CAFA. [read post]
10 Sep 2022, 2:49 am
Author User:Jynto Licence CCO 1.0 Source Wikimedia Commons Jane LambertPatents Court (Mr Justice Mellor) Neurim Pharmaceuticals (1991) Ltd and another v Teva UK Ltd [2022] EWHC 954 (Pat) (26 April 2022)This was an application by  Neurim Pharmaceuticals (1991) Ltd., the proprietor of European patent (UK)  3,103,443, and Flynn Pharma Limited, Neurim's exclusive licensee, for an interim injunction [read post]
17 May 2009, 9:55 pm
By Andrew Williams -- Last Thursday, the Federal Circuit affirmed the decision of the District Court for the District of New Jersey denying a request by Altana Pharma and Wyeth (collectively "Altana") for a preliminary injunction to prevent Teva Pharmaceuticals ("Teva") from marketing a generic version of the antiulcer drug Protonix ®. [read post]
25 Jul 2011, 1:34 am by Lawrence B. Ebert
Mylan Inc. and Momenta Pharmaceuticals Inc. have each challenged Teva's patents on Copaxone.Separately, note the postGeneric drugs have slower approval route than new ones, backlogged by FDA staff shortage [read post]
23 Dec 2021, 8:48 pm by Patent Docs
One such decision arose earlier this month when the Federal Circuit affirmed a determination of non-obviousness by the Patent Trial and Appeal Board in an inter partes review proceeding, that opinion captioned Teva Pharmaceuticals USA, Inc. v. [read post]
12 Oct 2010, 9:59 pm by Patent Docs
§ 2201) in the Hatch-Waxman context in Teva Pharmaceuticals USA, Inc. v. [read post]
29 Jul 2013, 9:26 pm by Patent Docs
This principle of patent law was reaffirmed by the Federal Circuit last week in Teva Pharmaceuticals USA, Inc. v. [read post]
5 Jun 2016, 11:43 am by Jim Caton
Zecuity, a transdermal patch produced by Teva Pharmaceuticals and approved by theThe post Teva Migraine Patch Undergoes New Scrutiny appeared first on Legal Reader. [read post]
31 Mar 2014, 8:47 pm by Patent Docs
By Andrew Williams -- Earlier today, the Supreme Court granted certiorari in the Teva Pharmaceuticals USA, Inc. v. [read post]